Allumiqs Corporation, Halifax, NS B3H 0A8, Canada.
Craig's Cause Pancreatic Cancer Society, Halifax, NS B3K 5M3, Canada.
Curr Oncol. 2024 Oct 16;31(10):6191-6204. doi: 10.3390/curroncol31100461.
Pancreatic cancer is a complex malignancy associated with poor prognosis and high symptom burden. Optimal patient care relies on the integration of various sectors in the healthcare field as well as innovation through research. The Canadian National Pancreas Conference (NPC) was co-organized and hosted by Craig's Cause Pancreatic Cancer Society and The Royal College of Physicians and Surgeons in November 2023 in Montreal, Canada. The conference sought to bridge the gap between Canadian healthcare providers and researchers who share the common goal of improving the prognosis, quality of life, and survival for patients with pancreatic cancer. The accredited event featured discussion topics including diagnosis and screening, value-based and palliative care, pancreatic enzyme replacement therapy, cancer-reducing treatment, and an overview of the current management landscape. The present article reviews the NPC sessions and discusses the presented content with respect to the current literature.
胰腺癌是一种预后不良且症状负担重的复杂恶性肿瘤。优化患者护理依赖于医疗保健领域各个部门的整合以及通过研究进行创新。加拿大国家胰腺会议（NPC）于 2023 年 11 月在加拿大蒙特利尔由 Craig's Cause 胰腺癌协会和皇家内科医师学院共同组织和主办。该会议旨在弥合加拿大医疗保健提供者和研究人员之间的差距，他们的共同目标是改善胰腺癌患者的预后、生活质量和生存率。该认证活动的讨论主题包括诊断和筛查、基于价值的和姑息治疗、胰酶替代治疗、癌症减少治疗以及当前管理领域的概述。本文综述了 NPC 会议，并根据当前文献讨论了所呈现的内容。
